Literature DB >> 10993082

TFIIH is negatively regulated by cdk8-containing mediator complexes.

S Akoulitchev1, S Chuikov, D Reinberg.   

Abstract

The mammalian cyclin-dependent kinase 8 (cdk8) gene has been linked with a subset of acute lymphoblastic leukaemias, and its corresponding protein has been functionally implicated in regulation of transcription. Mammalian cdk8 and cyclin C, and their respective yeast homologues, Srb10 and Srb11, are components of the RNA polymerase II holoenzyme complex where they function as a protein kinase that phosphorylates the carboxy-terminal domain (CTD) of the largest subunit of RNA polymerase II (ref. 7). The yeast SRB10 and SRB11 genes have been implicated in the negative regulation of transcription. The cdk8/cyclin C protein complex is also found in a number of mammalian Mediator-like protein complexes, which repress activated transcription independently of the CTD in vitro. Here we show that cdk8/cyclin C can regulate transcription by targeting the cdk7/cyclin H subunits of the general transcription initiation factor IIH (TFIIH). cdk8 phosphorylates mammalian cyclin H in the vicinity of its functionally unique amino-terminal and carboxy-terminal alpha-helical domains. This phosphorylation represses both the ability of TFIIH to activate transcription and its CTD kinase activity. In addition, mimicking cdk8 phosphorylation of cyclin H in vivo has a dominant-negative effect on cell growth. Our results link the Mediator complex and the basal transcription machinery by a regulatory pathway involving two cyclin-dependent kinases. This pathway appears to be unique to higher organisms.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10993082     DOI: 10.1038/35024111

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  146 in total

1.  Differential control of transcription by DNA-bound cyclins.

Authors:  T Y Kim; W G Kaelin
Journal:  Mol Biol Cell       Date:  2001-07       Impact factor: 4.138

2.  Opposing effects of Ctk1 kinase and Fcp1 phosphatase at Ser 2 of the RNA polymerase II C-terminal domain.

Authors:  E J Cho; M S Kobor; M Kim; J Greenblatt; S Buratowski
Journal:  Genes Dev       Date:  2001-12-15       Impact factor: 11.361

3.  Requirement of TRAP/mediator for both activator-independent and activator-dependent transcription in conjunction with TFIID-associated TAF(II)s.

Authors:  Hwa Jin Baek; Sohail Malik; Jun Qin; Robert G Roeder
Journal:  Mol Cell Biol       Date:  2002-04       Impact factor: 4.272

4.  The C-terminal domain phosphatase and transcription elongation activities of FCP1 are regulated by phosphorylation.

Authors:  Erika M Friedl; William S Lane; Hediye Erdjument-Bromage; Paul Tempst; Danny Reinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-18       Impact factor: 11.205

Review 5.  RNA polymerase II carboxy-terminal domain kinases: emerging clues to their function.

Authors:  Gregory Prelich
Journal:  Eukaryot Cell       Date:  2002-04

6.  The program of androgen-responsive genes in neoplastic prostate epithelium.

Authors:  Peter S Nelson; Nigel Clegg; Hugh Arnold; Camari Ferguson; Michael Bonham; James White; Leroy Hood; Biaoyang Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-16       Impact factor: 11.205

Review 7.  The human Mediator complex: a versatile, genome-wide regulator of transcription.

Authors:  Dylan J Taatjes
Journal:  Trends Biochem Sci       Date:  2010-03-17       Impact factor: 13.807

Review 8.  Selectivity and potency of cyclin-dependent kinase inhibitors.

Authors:  Jayalakshmi Sridhar; Nagaraju Akula; Nagarajan Pattabiraman
Journal:  AAPS J       Date:  2006-03-24       Impact factor: 4.009

9.  Bur1 kinase is required for efficient transcription elongation by RNA polymerase II.

Authors:  Michael-Christopher Keogh; Vladimir Podolny; Stephen Buratowski
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

10.  MED12 mutations link intellectual disability syndromes with dysregulated GLI3-dependent Sonic Hedgehog signaling.

Authors:  Haiying Zhou; Jason M Spaeth; Nam Hee Kim; Xuan Xu; Michael J Friez; Charles E Schwartz; Thomas G Boyer
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.